27th Jul 2005 13:50
BTG PLC27 July 2005 BTG plc: Change in FTSE Classification and Result of AGM London, UK, 27 July 2005: BTG plc (LSE: BGC), the medical innovations company,announces that, following its recent strategic review and a successfulapplication to the London Stock Exchange, the Company's FTSE classification willchange from sub-sector 581 - Business Support Services to sub-sector 482 -Biotechnology. The change will be effective on 19 September 2005. BTG also announces that at its Annual General Meeting earlier today allResolutions were approved. Enquiries: BTG plc Financial Dynamics Andy Burrows Ben AtwellTel: +44 (0) 20 7575 1741 Tel: +44 (0) 20 7831 3113 About BTG BTG acquires rights to early stage pharmaceuticals and other medicaltechnologies from a global network of corporations, universities and researchinstitutions. We apply resources including finance, intellectual property andproject management skills to fund and manage outsourced preclinical and clinicaldevelopment programmes. We then commercialise the technologies by licensing topharmaceutical or device companies, or by creating companies to exploit them.Our pipeline comprises around 50 assets at varying stages of development,contributing to an increasing range of products marketed by our licensees. BTGoperates from London, Philadelphia and Tokyo. For further information visit:www.btgplc.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
BTG